Virus de la grippe
Les inhibiteurs du virus de la grippe sont des composés qui interfèrent avec la réplication et la propagation des virus de la grippe. Ces inhibiteurs sont essentiels pour rechercher des stratégies antivirales, comprendre le cycle de vie du virus de la grippe et développer des traitements et des vaccins efficaces. Les inhibiteurs de la grippe peuvent cibler différentes étapes du processus de réplication virale, y compris l'entrée virale, la réplication et la libération. Chez CymitQuimica, nous offrons une large gamme d'inhibiteurs de haute qualité du virus de la grippe pour soutenir vos recherches en virologie, maladies infectieuses et développement de médicaments antiviraux.
299 produits trouvés pour "Virus de la grippe"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Anti-Influenza agent 3
Compound 11h: Potent, low-toxicity anti-influenza, inhibits M2 ion channels. EC50: 3.29μM (H3N2), 2.45μM (H1N1).Formule :C16H22ClNOSCouleur et forme :SolidMasse moléculaire :311.87cis-RdRP-IN-5
Cis-RdRP-IN-5 is an effective inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), employed in influenza virus research.Formule :C23H21N3O5Couleur et forme :SolidMasse moléculaire :419.43Cap-dependent endonuclease-IN-5
CAS :Cap-dependent endonuclease-IN-5 inhibits CEN and fights influenza with low toxicity and good in vivo properties.Formule :C27H21F2N3O4S2Couleur et forme :SolidMasse moléculaire :553.60Massarilactone H
CAS :Massarilactone H, a polyketide, is a neuraminidase inhibitor, with an IC 50 of 8.18 µM .Formule :C11H12O5Couleur et forme :SolidMasse moléculaire :224.21Cap-dependent endonuclease-IN-2
Cap-dependent endonuclease-IN-2 strongly blocks influenza A virus RNA polymerase; it's a CEN inhibitor.Formule :C30H24FN3O7SCouleur et forme :SolidMasse moléculaire :589.59VV261
CAS :VV261 is an orally active inhibitor of the Influenza Virus. It exhibits activity against the Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) and the Lymphocytic Choriomeningitis Virus (LCMV), with EC50 values of 0.89 and 0.15, respectively.Formule :C28H34FN3O11Couleur et forme :SolidMasse moléculaire :607.58Neuraminidase-IN-18
CAS :Neuraminidase-IN-18 (compound N5), a novel polyheterocyclic neuraminidase (NA) inhibitor, demonstrates significant inhibitory activity against H5N1 NA, with an IC 50 of 0.14 μM against the wild-type H5N1 NA and 0.27 μM against the H5N1-H274Y mutant NA. This compound effectively binds to NAs, inhibiting influenza virus replication at the cellular level [1].Formule :C22H18FN3O3SCouleur et forme :SolidMasse moléculaire :423.46RdRP-IN-5
CAS :RdRP-IN-5 (compound 20), a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), has potential application in influenza research [1].Formule :C23H21N3O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :419.43RdRP-IN-4
RdRP-IN-4, an oral arylbenzohydrazide, inhibits influenza A/B by targeting PB1 of RdRP, with EC50s of 53 nM (H1N1) and 20 nM (Flu B), and aids infected mice.Formule :C17H17Br2N3O2Couleur et forme :SolidMasse moléculaire :455.14Cap-dependent endonuclease-IN-6
CAS :Cap-dependent endonuclease-IN-6 (compound 13) is a Cap-dependent endonuclease (CEN) inhibitor that inhibits influenza virus.Formule :C23H21N3O3SCouleur et forme :SolidMasse moléculaire :419.5trans-RdRP-IN-5
Trans-RdRP-IN-5 is a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), with applications in influenza virus research.Formule :C23H21N3O5Couleur et forme :SolidMasse moléculaire :419.43Laninamivir trifluoroacetate
CAS :Laninamivir trifluoroacetate, a long-acting antiviral, treats and prevents Influenza A and B via nasal spray.Formule :C15H23F3N4O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :460.363Cap-dependent endonuclease-IN-7
CAS :Cap-dependent endonuclease-IN-7, a potent CEN inhibitor, blocks viral mRNA synthesis and virus spread, with research use for influenza A, B, C.Formule :C36H28FN3O7SCouleur et forme :SolidMasse moléculaire :665.69Carbodine
CAS :Carbodine is an antiviral targeting CTP synthetase, effective against influenza A0/PR-8/34 and A2/Aichi/2/68.Formule :C10H15N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :241.24Cap-dependent endonuclease-IN-14
CAS :Cap-dependent endonuclease-IN-14 hinders CEN and could treat influenza virus infections. (Patent CN113620948A, compound 1-c).Formule :C30H23FN2O6SCouleur et forme :SolidMasse moléculaire :558.58UH15-38
CAS :UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.Formule :C26H27N5O2Degré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :441.53Cap-dependent endonuclease-IN-1
CAS :Cap-dependent endonuclease-IN-1: potent, oral inhibitor with antiviral properties against influenza.Formule :C27H22F2N2O6SDegré de pureté :99.53% - 99.61%Couleur et forme :SolidMasse moléculaire :540.54FGI-106 tetrahydrochloride
CAS :FGI-106 tetrahydrochloride demonstrates potent inhibitory activity across a broad spectrum of viruses, including those causing hemorrhagic fevers such as EbolaFormule :C28H42Cl4N6Degré de pureté :99.68%Couleur et forme :SolidMasse moléculaire :604.48Ref: TM-T11281L
1mg82,00€5mg161,00€10mg245,00€25mg406,00€50mg572,00€100mg772,00€200mg1.035,00€1mL*10mM (DMSO)207,00€Cap-dependent endonuclease-IN-9
CAS :Cap-dependent endonuclease-IN-9, a strong influenza inhibitor, shows low toxicity, good pharmacokinetics, and dynamic action.
Formule :C29H22F2N4O7SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :608.57
